Engagement Is the Business Model. Alliance Is the Treatment.

Dartmouth has spent seven years building a therapy chatbot — and you still can't download it.

Therabot, developed at Dartmouth's Center for Technology and Behavioral Health, is the first generative AI mental health chatbot to show clinical results in a published trial. Yet as the Valley News reported this week, it exists only inside approved research studies, and psychiatrist Michael Heinz, its lead clinical investigator, can't say when — or whether — it will reach the market. Meanwhile, apps calling themselves AI therapists are downloadable today, some even borrowing the Therabot name with no connection to Dartmouth.

That gap — between the careful, clinician-led version of this technology and the engagement-optimized version already in millions of pockets — was the story of this week. Not in one place, but in four: a federal courtroom in Oakland, statehouses in Sacramento and Montpelier, a congressional letter to the VA, and a research lab in New Hampshire. Each is wrestling with the same underlying question, and it isn't "can AI help with mental health?" It's: who holds the clinical relationship, and who is accountable when it breaks?

Start in Oakland. On Tuesday, a landmark federal trial opened after the Ninth Circuit refused to delay it, consolidating claims from 29 state attorneys general that Meta and TikTok designed their products in ways that harmed young users (Medical Daily, Aug 12). What's notable is the shape of the allegation: it's about design, not content — the claim that features were engineered to maximize engagement among minors, and that the companies understood the consequences. Nothing has been proven, and the science on social media and teen mental health remains genuinely contested. But the legal system is now stress-testing a business model, and the model on trial is engagement-for-its-own-sake.

That same model is what California lawmakers are trying to wall off from care itself. Senate Bill 903, authored by Sen. Steve Padilla and covered by CalMatters earlier this month, would ban companies from advertising chatbots as therapy and prohibit AI from making therapeutic decisions without review by a licensed professional. The line Padilla describes is precise: AI can handle administrative work and support clinicians — it cannot practice psychotherapy. Le Ondra Clark Harvey of the California Behavioral Health Association put the stakes plainly: "The difference between a licensed clinician and an automated response is not technical. It can be life altering." Vermont has already drawn a similar line — its H.816, signed in June, requires a licensed professional to review AI-generated mental health advice before it reaches a patient.

I find it telling that the strongest case for AI in mental health this week came from someone building it under exactly those constraints. Heinz's team trained Therabot from scratch on data matched to therapeutic best practices, hosts it on university servers, and holds it to a design principle most consumer apps invert: "We are never optimizing toward engagement for the sake of engagement," he told the Valley News. "It really is optimized toward measures of human wellbeing." His use case is worth sitting with — a patient leaves a session with an assignment and, instead of facing the week alone, has a clinically supervised tool alongside them for the exposures and exercises. That's not a replacement for a therapist. That's the space between sessions, finally visible.

The fourth story explains why any of this matters with such urgency: the humans are stretched thin. Sixty-two House Democrats gave the VA until August 14 to produce facility-level data on mental health staffing, citing the department's own figures — more than 300 psychologists and roughly 700 social workers lost since the start of the current administration, and an inspector general finding that 57% of facilities report severe psychology staffing shortages (Medical Daily, Aug 10). Buried in that letter is the detail I keep returning to: trauma-focused therapies run as structured multi-week protocols that depend on continuity. A veteran reassigned mid-protocol often restarts from zero, recounting their trauma to a stranger. Headcount numbers miss this. Continuity is the treatment.

Put the four together and the pattern names itself. Courts are interrogating engagement-driven design. Legislators are ring-fencing the practice of therapy for licensed clinicians. The clinical workforce is too depleted to pretend the status quo is fine. And the most credible AI research is the kind that accepts clinical accountability as a design constraint rather than a compliance burden.

The wrong conclusion is that technology has no place here. The access gap is real — Heinz is right that a chatbot doesn't keep office hours or a waitlist, and the VA data shows what happens when the supply of clinicians erodes. The right conclusion is narrower and more useful: the value of AI in mental health scales with its proximity to a real clinical relationship, not its distance from one. Tools that extend a therapist's sight into the week between appointments, that preserve context when a patient meets a new clinician so nobody restarts from zero, that protect the therapeutic alliance instead of substituting for it — those pass the test every arena applied this week. Tools that quietly become the relationship do not.

The engagement economy has had its decade with our attention. The evidence arriving from courtrooms, statehouses, and clinics suggests our minds deserve a different architecture — one where a qualified human is accountable for the person on the other end, and the software works for that human. That's the direction this week pointed. I don't think it's turning back.